RemSleep Holdings, Inc. engages in the design and manufacture of medical devices and products for the treatment of sleep apnea and other respiratory conditions. The company is headquartered in Clearwater, Florida. The company went IPO on 2008-12-15. The Company’s focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. Its patented DeltaWave product is a nasal-pillow type interface that is designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. DeltaWave delivers comfort and airflow for better sleep and improved CPAP therapy. The Company’s product is manufactured by mold makers. The company has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.
RMSL stock price ended at $0 on 木曜日, after rising NaN%
On the latest trading day Jan 22, 2026, the stock price of RMSL rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 340.2K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 4.5M shares were traded, amounting to a market value of approximately --.